UnitedHealth Group (NYSE:UNH) Stock Price Expected to Rise, KeyCorp Analyst Says

UnitedHealth Group (NYSE:UNH) had its price target boosted by stock analysts at KeyCorp from $400.00 to $475.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the healthcare conglomerate’s stock. KeyCorp’s price target suggests a potential upside of 10.63% from the stock’s previous close.

Other equities analysts have also issued research reports about the company. Cantor Fitzgerald reiterated an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, June 11th. Morgan Stanley boosted their target price on UnitedHealth Group from $453.00 to $468.00 and gave the stock an “overweight” rating in a research report on Tuesday, June 30th. HC Wainwright set a $492.00 target price on UnitedHealth Group in a research note on Wednesday, May 27th. Truist Financial upped their target price on shares of UnitedHealth Group from $395.00 to $440.00 and gave the stock a “buy” rating in a research note on Monday, June 1st. Finally, Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $423.96.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $429.34 on Tuesday. The stock has a fifty day moving average of $400.56 and a 200-day moving average of $339.71. UnitedHealth Group has a one year low of $234.60 and a one year high of $434.30. The company has a market capitalization of $389.90 billion, a PE ratio of 32.43, a price-to-earnings-growth ratio of 1.71 and a beta of 0.62. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.80 and a current ratio of 0.80.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, topping the consensus estimate of $6.76 by $0.47. The company had revenue of $111.65 billion for the quarter, compared to analyst estimates of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.UnitedHealth Group’s revenue for the quarter was up 2.0% compared to the same quarter last year. During the same quarter last year, the firm earned $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, equities analysts anticipate that UnitedHealth Group will post 18.32 EPS for the current fiscal year.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the transaction, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at $6,320,775. The trade was a 4.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.28% of the stock is owned by company insiders.

Hedge Funds Weigh In On UnitedHealth Group

Several institutional investors and hedge funds have recently modified their holdings of UNH. Vanguard Group Inc. increased its holdings in shares of UnitedHealth Group by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 91,600,260 shares of the healthcare conglomerate’s stock worth $30,238,162,000 after purchasing an additional 995,210 shares during the period. State Street Corp grew its position in UnitedHealth Group by 2.5% in the fourth quarter. State Street Corp now owns 45,232,170 shares of the healthcare conglomerate’s stock valued at $14,931,592,000 after purchasing an additional 1,119,834 shares in the last quarter. Capital World Investors boosted its stake in shares of UnitedHealth Group by 3.8% during the 4th quarter. Capital World Investors now owns 22,591,042 shares of the healthcare conglomerate’s stock worth $7,457,723,000 after acquiring an additional 824,120 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of UnitedHealth Group by 3.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 18,829,054 shares of the healthcare conglomerate’s stock worth $6,215,660,000 after purchasing an additional 680,077 shares in the last quarter. Finally, Capital International Investors grew its position in UnitedHealth Group by 6.6% in the fourth quarter. Capital International Investors now owns 18,655,111 shares of the healthcare conglomerate’s stock valued at $6,158,734,000 after acquiring an additional 1,155,162 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Wells Fargo raised its price target on UnitedHealth Group to $485 from $397 and kept an overweight rating, signaling confidence that the stock can move higher from current levels. Read More
• Positive Sentiment: Multiple recent articles point to UnitedHealth’s ongoing recovery, with investors encouraged by management’s turnaround efforts and the company’s ability to regain momentum after last year’s challenges.
• Positive Sentiment: Several analysts remain bullish on UNH overall, and recent price targets cluster above the current trading range, reinforcing the view that Wall Street expects more upside if earnings execution stays strong.
• Neutral Sentiment: Coverage ahead of earnings is centered on key operating metrics such as membership, medical costs, and profitability, which means the stock may stay volatile until the company reports results and offers guidance.
• Neutral Sentiment: Articles discussing Guardant’s Shield test and broader preventive-care themes are more about UnitedHealth’s care delivery strategy than an immediate earnings catalyst, so their stock impact appears limited for now.
• Neutral Sentiment: Social-media and options chatter suggest traders are pricing in a sizable post-earnings move, but that mainly reflects uncertainty rather than a clear directional signal.
• Negative Sentiment: Some analysts and press coverage note pressure from membership declines and lingering concerns about rising healthcare costs, both of which could weigh on near-term earnings if they show up in the quarter.
• Negative Sentiment: Technical commentators have warned that UNH could be vulnerable to a pullback after its strong rally if earnings or guidance fail to meet elevated expectations.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.